Literature DB >> 4621797

Immunofluorescence staining of group B coxsackieviruses.

M L French, N J Schmidt, R W Emmons, E H Lennette.   

Abstract

Studies were conducted on the sensitivity and specificity of indirect fluorescent-antibody (FA) staining for identification of group B coxsackieviruses. Antisera produced in four different species (monkeys, rabbits, horses, hamsters) and immune ascitic fluids prepared in mice were compared for suitability in FA staining. The horse antisera showed high titers of nonspecific staining, and the rabbit antisera showed relatively low homologous FA titers. Immune reagents from monkeys, hamsters, and mice were used for homologous and heterologous testing against cell cultures infected with the various group B coxsackieviruses. Antisera or immune ascitic fluids produced in these three species showed some heterotypic and nonspecific staining at low dilutions, with the monkey antisera showing the highest heterotypic titers. However, the immune reagents could be diluted to a point where they gave no heterotypic reactivity, but still showed characteristic homotypic staining. Heterotypic staining appeared as diffuse, low-level staining of the cells, whereas homotypic staining revealed characteristic, brightly staining aggregates of viral antigen in the cytoplasm of the infected cells. By using hamster immune sera, appropriately diluted to eliminate heterotypic staining and yet give strong homotypic staining, it was possible to identify correctly 79 (93%) of 85 field strains of group B coxsackieviruses at the first passage level in BS-C-1 cells; the remainder of the strains were identified after two passages in BS-CS-1 cells. No incorrect identifications were made. A limited number of field strains of group B coxsackieviruses were passed into rhesus monkey kidney and human fetal diploid kidney cells, and these were all correctly identified by FA staining, even the strains which failed to produce a cytopathic effect in the human fetal diploid kidney cells. Two human heart and brain tissues from which coxsackievirus type B4 had been isolated failed to show homotypic FA staining in excess of nonspecific or heterotypic staining.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4621797      PMCID: PMC380276          DOI: 10.1128/am.23.1.54-61.1972

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  18 in total

1.  Application of direct and indirect immunofluorescence for identification of enteroviruses and titrating their antibodies.

Authors:  J L RIGGS; G C BROWN
Journal:  Proc Soc Exp Biol Med       Date:  1962 Aug-Sep

2.  Antigenic variants of coxsackievirus type A24.

Authors:  N J Schmidt; E H Lennette
Journal:  Am J Epidemiol       Date:  1970-01       Impact factor: 4.897

3.  Detection of cross-reactions by immunofluorescence within the picornavirus group.

Authors:  R K Chaudhary; J C Westwood
Journal:  Can J Microbiol       Date:  1970-07       Impact factor: 2.419

4.  The production of fluorescent antibody reagents for virus diagnosis in the albino mouse. I. Hyperimmune anti-species serum.

Authors:  R G Sommerville
Journal:  Arch Gesamte Virusforsch       Date:  1967

5.  Coxsackie virus B3 calcific pancarditis and hydrops fetalis.

Authors:  H R Bates
Journal:  Am J Obstet Gynecol       Date:  1970-02-15       Impact factor: 8.661

6.  Progressive Coxsackie viral pancarditis and nephritis.

Authors:  G E Burch; H L Colcolough
Journal:  Ann Intern Med       Date:  1969-11       Impact factor: 25.391

7.  Immunofluorescent localization of coxsackievirus B antigen in the kidney observed at routine autopsy.

Authors:  G E Burch; K C Chu; H L Colcolough; R S Sohal
Journal:  Am J Med       Date:  1969-07       Impact factor: 4.965

8.  Coxsackie B viral myocarditis and valvulitis identified in routine autopsy specimens by immunofluorescent techniques.

Authors:  G E Burch; S C Sun; H L Colcolough; R S Sohal; N P DePasquale
Journal:  Am Heart J       Date:  1967-07       Impact factor: 4.749

9.  Immunofluorescence studies on Coxsackie group A. I. Localization of viral antigen in infected primary human amnion cells.

Authors:  E Zalan; A E Kelen; N A Labzoffsky
Journal:  Arch Gesamte Virusforsch       Date:  1965

10.  WHO collaborative studies on enterovirus reference antisera. Third report.

Authors:  J L Melnick; B Hampil
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

View more
  5 in total

1.  Comparison between indirect immunofluorescence and microneutralization for detection of antibodies to polioviruses.

Authors:  C Pettit; L L Minnich; Z M Shehab; C G Ray
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

2.  Persistent infection of rat insulinoma cells with Coxsackie B4 virus. Brief report.

Authors:  J A Frank; E V Schmidt; R E Smith; C M Wilfert
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

3.  Antibody levels in human sera measured by the fluorescent-antibody technique against the coxsackie B viruses types 1-5 grown in HEp2 cells compared with results obtained by neutralization.

Authors:  K M MacWilliam; M A Cooper
Journal:  J Clin Pathol       Date:  1974-10       Impact factor: 3.411

Review 4.  Viral myocarditis. A review.

Authors:  J F Woodruff
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

5.  Factors involved in enzyme-linked immunoassay of viruses and evaluation of the method for identification of enteroviruses.

Authors:  J E Herrmann; R M Hendry; M F Collins
Journal:  J Clin Microbiol       Date:  1979-08       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.